Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Rimini Street
RMNI
$452M
| $1.28M | ﹤0.01% |
340,145
+100,619
| +42% | +$336K |
|
2377
International Money Express
IMXI
$372M
| $1.27M | ﹤0.01% |
125,800
-112,800
| -47% | -$1.29M |
|
2378
RUM Group Inc
RUM
$1.7B
| $1.27M | ﹤0.01% |
+141,100
| New | +$1.21M |
|
2379
VanEck Pharmaceutical ETF
PPH
$914M
| $1.27M | ﹤0.01% |
+14,400
| New | +$1.25M |
|
2380
JPMorgan Core Plus Bond ETF
JCPB
$13.9B
| $1.26M | ﹤0.01% |
+26,800
| New | +$1.24M |
|
|
JFIN
2381
Jiayin Group
JFIN
$116M
| $1.26M | ﹤0.01% |
78,722
+16,922
| +27% | +$230K |
|
2382
Intrepid Potash
IPI
$447M
| $1.26M | ﹤0.01% |
35,271
-4,400
| -11% | -$150K |
|
2383
LGL Group
LGL
$45.1M
| $1.26M | ﹤0.01% |
165,321
-5,500
| -3% | -$37.1K |
|
2384
John Hancock Multifactor Mid Cap ETF
JHMM
$5.97B
| $1.26M | ﹤0.01% |
20,600
-1,127
| -5% | -$65K |
|
2385
Pacer Trendpilot US Large Cap ETF
PTLC
$3.3B
| $1.26M | ﹤0.01% |
24,800
+18,100
| +270% | +$885K |
|
|
FFWM
2386
DELISTED
First Foundation Inc
FFWM
| $1.26M | ﹤0.01% |
+246,114
| New | +$1.26M |
|
2387
Global X MLP & Energy Infrastructure ETF
MLPX
$3.61B
| $1.25M | ﹤0.01% |
+19,900
| New | +$1.21M |
|
2388
Hagerty
HGTY
$1.17B
| $1.25M | ﹤0.01% |
123,168
-25,600
| -17% | -$239K |
|
2389
PCB Bancorp
PCB
$392M
| $1.24M | ﹤0.01% |
59,301
+5,200
| +10% | +$101K |
|
|
AXON
2390
Axon Enterprise
AXON
$45.6B
| $1.24M | ﹤0.01% |
+1,500
| New | +$1.02M |
|
2391
908 Devices
MASS
$339M
| $1.24M | ﹤0.01% |
174,100
+29,500
| +20% | +$164K |
|
2392
Great Elm Group
GEG
$67.4M
| $1.24M | ﹤0.01% |
596,912
-12,928
| -2% | -$26.1K |
|
2393
Fidelity MSCI Health Care Index ETF
FHLC
$3.27B
| $1.23M | ﹤0.01% |
+19,300
| New | +$1.23M |
|
2394
United Airlines
UAL
$41.5B
| $1.23M | ﹤0.01% |
15,495
-2,159,763
| -99% | -$159M |
|
|
GOLD
2395
Gold.com Inc
GOLD
$1.21B
| $1.23M | ﹤0.01% |
55,600
+25,400
| +84% | +$564K |
|
2396
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.94B
| $1.23M | ﹤0.01% |
+59,300
| New | +$1.23M |
|
2397
OmniAb
OABI
$287M
| $1.23M | ﹤0.01% |
707,550
+680,950
| +2,560% | +$1.14M |
|
2398
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.97B
| $1.23M | ﹤0.01% |
49,900
-102,196
| -67% | -$2.51M |
|
2399
Dimensional US Targeted Value ETF
DFAT
$14.6B
| $1.23M | ﹤0.01% |
22,800
+1,000
| +5% | +$50.9K |
|
2400
Amplify Blockchain Technology ETF
BLOK
$1.09B
| $1.23M | ﹤0.01% |
+21,500
| New | +$973K |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.